ADAMTS13 and liver disorder: In this study, we assessed VWF and ADAMTS13 parameters, cVWF levels, and markers of fibrinolytic activity in patients with acute and chronic liver disease across varying disease severities, as well as in patients with sepsis without underlying liver disease.